Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.7
60.05%
60%
—
84.02%
60%
—
5 Years
Score5.7
Net Growth60.05%
Net Trend60%
Net Income Consistency—
Rev Growth84.02%
Rev Trend60%
Revenue Consistency—
Editas Medicine Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 90M to $ 40M and net income went from -$ 109M to -$ 160M. Revenue increased in 3 of those 5 years; net income in 3.
Across Editas Medicine Inc's full reported history, from 2016 to 2025, revenue grew from $ 6M to $ 40M and net income went from -$ 97M to -$ 160M. Revenue increased in 60% of the years measured; net income in 50%.
Editas Medicine Inc currently holds a 5-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.84 | — |
1 Year2025-08-12 | $ 2.29 | 24.02% |
5 Years2021-08-12 | $ 65.35 | -95.65% |
10 Years2016-08-12 | $ 20.11 | -85.88% |
All Time2016-02-03 | $ 18.20 | -84.40% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2016-02-03 |
|---|---|---|---|---|---|
| Price | $ 2.84 | $ 2.29 | $ 65.35 | $ 20.11 | $ 18.20 |
| Return | — | 24.02% | -95.65% | -85.88% | -84.40% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 47M | -$ 73M | $ 211M |
| 2025 | $ 40M | -$ 160M | $ 146M |
| 2024 | $ 32M | -$ 237M | $ 269M |
| 2023 | $ 78M | -$ 153M | $ 323M |
| 2022 | $ 19M | -$ 204M | $ 344M |
| 2021 | $ 25M | -$ 185M | $ 499M |
| 2020 | $ 90M | -$ 109M | $ 402M |
| 2019 | $ 20M | -$ 133M | $ 457M |
| 2018 | $ 31M | -$ 109M | $ 368M |
| 2017 | $ 13M | -$ 120M | $ 329M |
| IPO2016 | $ 6M | -$ 97M | $ 185M |
Explore beyond EDIT
You're looking at Editas Medicine Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
